Company Profile
Armata Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- ARMP
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.70 USD (0.00%)
Close
Last updated: August 6, 2026
291M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ARMP was little changed and closed at $4.70. No new same-company headline was identified in the current news window.
Company overview
Business overview
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections. Its platform aims to use phage biology to address resistant pathogens.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE American, Armata sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, anti-infective differentiation, and the ability to build a durable phage-therapy story.
Position Within the Biotechnology Landscape
Armata is a niche anti-infective catalyst name whose valuation depends on development progress.
Future catalysts
Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing. The market will care about whether the clinical path stays open.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Armata Pharmaceuticals (ARMP)?
Armata Pharmaceuticals (ARMP) most recently closed at 4.70 USD, a 0.00% move versus the previous session.
What is the market cap of Armata Pharmaceuticals (ARMP)?
Armata Pharmaceuticals currently has a market capitalization of 291M USD on BioPharmSignal.
What does Armata Pharmaceuticals do?
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections. Its platform aims to use phage biology to address resistant pathogens.
On which exchange is ARMP stock listed?
Armata Pharmaceuticals (ARMP) is associated with NYSE, United States, Biopharma.
What is Armata?
Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing.
Which conditions is Armata Pharmaceuticals targeting with Armata?
Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing.
How does Armata Pharmaceuticals describe recent progress with Armata?
Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing.
What is Pharmaceuticals?
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections.